NANOVACCINE FOR ELICITING BNABS AGAINST HIV-1
$2,000,000
| Recipient | NEOVAXSYN INC UEI EHMTBALCKFE8 |
|---|---|
| Award ID | 75N93024C00019 |
| Award amount | $2,000,000 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Small business |
| Start date | Jul 1, 2024 |
| End date | Jun 30, 2028 |
| Place of performance | AMES, IA |
| Record updated | Jun 25, 2026 |
View the official award record
More awards won by NEOVAXSYN INC
THE CONTRACTOR SHALL UTILIZE NANOPARTICLES TO DELIVER THE MPER-BASED IMMUNOGENS TO ELICIT BNABS AGAINST THE MPER OF HIV-1 GP41 TO DEVELOP A PROTECTIVE VACCINE AGAINST THE VIRUS.
Department of Health and Human Services · $300,000 · Jul 1, 2021
SBIR PHASE I
Department of Health and Human Services · $300,000 · Jul 1, 2022
DEVELOPMENT OF A NEXT-GENERATION IMMUNOPREVENTION PLATFORM AGAINST HIV-1
Department of Health and Human Services · $300,000 · Aug 1, 2024
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids